Literature DB >> 10602749

Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.

H M Donald1, W Scaife, S G Amyes, H K Young.   

Abstract

The sequence of the bla(ARI-1) gene from imipenem-resistant Acinetobacter baumannii 6B92 has been determined. The structural gene encodes a 273-amino-acid protein which is most related to the OXA class D beta-lactamases. The conserved S-T-F-K and K-T-G motifs were identified in the ARI-1 protein sequence, also named OXA-23, but significantly, a point mutation (Y-->F) was identified in the Y-G-N conserved motif, also known to function in the active site.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10602749      PMCID: PMC89654          DOI: 10.1128/AAC.44.1.196-199.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit.

Authors:  M J Weinbren; A P Johnson; M E Kaufmann; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

2.  BCM Search Launcher--an integrated interface to molecular biology data base search and analysis services available on the World Wide Web.

Authors:  R F Smith; B A Wiese; M K Wojzynski; D B Davison; K C Worley
Journal:  Genome Res       Date:  1996-05       Impact factor: 9.043

Review 3.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa.

Authors:  P Mugnier; I Podglajen; F W Goldstein; E Collatz
Journal:  Microbiology (Reading)       Date:  1998-04       Impact factor: 2.777

Review 5.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Molecular characterization of OXA-20, a novel class D beta-lactamase, and its integron from Pseudomonas aeruginosa.

Authors:  T Naas; W Sougakoff; A Casetta; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

7.  ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

Authors:  R Paton; R S Miles; J Hood; S G Amyes; R S Miles; S G Amyes
Journal:  Int J Antimicrob Agents       Date:  1993-02       Impact factor: 5.283

8.  Cloning and analysis of the polyhydroxyalkanoic acid synthase gene from an Acinetobacter sp.: evidence that the gene is both plasmid and chromosomally located.

Authors:  M A Schembri; R C Bayly; J K Davies
Journal:  FEMS Microbiol Lett       Date:  1994-05-01       Impact factor: 2.742

9.  Phosphate concentration regulates transcription of the Acinetobacter polyhydroxyalkanoic acid biosynthetic genes.

Authors:  M A Schembri; R C Bayly; J K Davies
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

Review 10.  Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination.

Authors:  R M Hall; C M Collis
Journal:  Mol Microbiol       Date:  1995-02       Impact factor: 3.501

View more
  74 in total

1.  Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.

Authors:  F Lopez-Otsoa; L Gallego; K J Towner; L Tysall; N Woodford; D M Livermore
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.

Authors:  D Aubert; L Poirel; J Chevalier; S Leotard; J M Pages; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents.

Authors:  Juliana Coelho; Neil Woodford; Mariya Afzal-Shah; David Livermore
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.

Authors:  Stéphane Corvec; Laurent Poirel; Thierry Naas; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

6.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 7.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

8.  Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.

Authors:  Yohei Doi; Jennifer M Adams; Kunikazu Yamane; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

9.  Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.

Authors:  Libera M Dalla-Costa; Juliana M Coelho; Helena A P H M Souza; Maria E S Castro; Christiane J N Stier; Karin L Bragagnolo; Alvaro Rea-Neto; Sergio R Penteado-Filho; David M Livermore; Neil Woodford
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Crystal structure of carbapenemase OXA-58 from Acinetobacter baumannii.

Authors:  Clyde A Smith; Nuno Tiago Antunes; Marta Toth; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.